Product Image

BCQ

Vital Nutrients
4.5
★ ★ ★ ★ ★
(813 ratings)
Bromelain 300 mg
Boswellia 600 mg
Turmeric 600 mg
Product Image
Score74
Substantial curcuminoids, boswellia, bromelain, and quercetin give the formula meaningful breadth. High cost and incomplete potency or delivery details are the main weaknesses.
How scoring works
Quantity:240 Capsule(s) • (80 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 74

Substantial curcuminoids, boswellia, bromelain, and quercetin give the formula meaningful breadth. High cost and incomplete potency or delivery details are the main weaknesses.
How scoring works
$102.90($1.28 per serving)
iHerb
$ 120.99
Amazon
$ 102.90
Vitacost
$ 120.99
Report prices

Analysis

Three capsules provide 600 mg total curcuminoids, 600 mg boswellia gum extract, 300 mg bromelain, and 300 mg quercetin. Every active has a substantial disclosed amount, making the formula much more focused than basic whole-herb combinations.

The combination covers inflammatory signaling, joint comfort, antioxidant activity, and enzyme-related support. Boswellia lacks a quantified total-acid or AKBA percentage, while bromelain lacks activity units and timing guidance.

The bottle provides 80 servings and requires three capsules each time. The large bottle lowers daily cost somewhat, but the serving remains expensive makes it better suited to buyers who value ingredient breadth more than low-cost single-ingredient supplementation.

Who is it for
  • Adults seeking high-potency botanical capsules
  • Users who value clearly listed botanical weights
  • People who can screen herb-specific medication and tolerance concerns
Best for
  • Comparing botanical form and dose
  • Goal-aligned supplement selection
  • Users who prefer high-potency botanical capsules

Pros

  • High disclosed curcuminoid amount
  • Substantial boswellia and bromelain amounts
  • Adds 300 mg quercetin
  • Every active is individually quantified

Cons

  • Requires three capsules
  • Boswellia acid percentage is not stated
  • Bromelain activity units are missing
  • The large bottle lowers daily cost somewhat, but the serving remains expensive

Warnings

  • Curcuminoids and bromelain may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Bromelain can cause digestive upset and may trigger reactions in people sensitive to pineapple
  • Turmeric can aggravate symptoms in people with gallstones or bile-duct obstruction
  • Quercetin may alter handling of some medicines, so complex medication regimens deserve review

Nutrient quality

81 Highest impact

Substantial boswellia, curcuminoids, bromelain, and quercetin offer broad inflammation support. Missing active percentages, enzyme activity, and absorption technology limit value confidence.

.

Ingredient transparency

84 Highest impact

Individual active weights are clearly disclosed. Some extract percentages, enzyme activity, or non-active label details remain incomplete.

.

Customer satisfaction

70 High impact

The supplied rating is favorable and the feedback base is adequate. No complaint-level evidence was supplied to assess recurring issues or purpose-specific experiences.

.

Value for money

56 Moderate impact

The serving cost is high relative to the certainty provided by the label. Substantial ingredients help, but disclosure gaps weaken category competitiveness.

.
Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A Goal FitC+ Strength of SupportA CoverageA+ Formula Quality
Boswellia · 600 mg

Boswellia, curcuminoids, bromelain, and quercetin create broad and strongly aligned pathway coverage. Substantial disclosed amounts give the combination more depth than most multi-ingredient formulas.

Missing active-standardization details make actual potency harder to verify. Bromelain activity units and an absorption system for the botanical extracts would materially strengthen confidence.

Study evidence
Boswellia Supportive 19 studies
Bromelain Supportive 12 studies
Joint Health
Impact
Highest effect
A- Goal FitB Strength of SupportB- CoverageA+ Formula Quality
Boswellia · 600 mg

Boswellia, curcuminoids, bromelain, and quercetin create broad support for inflammation-related joint comfort. The formula does not provide cartilage building blocks or a direct lubrication ingredient.

The ingredient amounts are substantial, but boswellic-acid standardization and bromelain enzyme activity are not disclosed. Boswellia, curcumin, and bromelain may increase bleeding tendency with anticoagulant or antiplatelet medicines.

Study evidence
Boswellia Supportive 24 studies
Bromelain Mixed 5 studies

Ingredients

IngredientAmount per serving
Boswellia serrata gum extract (Alpha Boswellic Acid, Beta Boswellic Acid)
600 mg
Bromelain
300 mg
Curcuma longa rhizome extract (Total Curcuminoids)
600 mg
Quercetin Dihydrate
300 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
Bromelain · 300 mg OverallScore37
F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value

The blend provides a meaningful amount of bromelain alongside boswellia, curcuminoids, and quercetin for broad inflammation-support use. Enzyme activity is not disclosed, so bromelain potency and consistency remain uncertain. The standard capsule and missing timing guidance also limit confidence in delivery for systemic use.

F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyF Value

The label reports a substantial Boswellia extract amount, but it does not state the concentration of total boswellic acids or AKBA. No absorption enhancer or advanced delivery system is identified, which leaves bioavailability uncertain. Bromelain and turmeric may increase bleeding risk with anticoagulant or antiplatelet medicines, and the high cost is difficult to justify without clearer standardization.

F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyF Value

The disclosed curcuminoid amount falls within a useful potency range, but the label does not identify a standardization percentage or absorption technology. Its multi-ingredient approach includes boswellia, bromelain, and quercetin, although those additions do not resolve the turmeric delivery gap. The high serving cost is difficult to justify for turmeric when active-form quality and bioavailability remain unclear.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  2. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  3. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support forBoswellia
  4. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  5. Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies.
    Brien S; Lewith G; Walker A; Hicks SM; Middleton D · Evidence-based complementary and alternative medicine : eCAM · 2024
    Narrative reviewJoint Health forBromelain
  6. Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis.
    Kasemsuk T; Saengpetch N; Sibmooh N; Unchern S · Clinical rheumatology · 2017
    Randomized trial40 participantsJoint Health forBromelain
  7. Therapeutic efficacy of bromelain in impacted third molar surgery: a randomized controlled clinical study.
    Ordesi P; Pisoni L; Nannei P; Macchi M; Borloni R; Siervo S · Quintessence international (Berlin, Germany : 1985) · 2016
    Randomized trial80 participantsAnti-Inflammatory Support forBromelain
  8. Effect of Oral Administration of Bromelain on Postoperative Discomfort After Third Molar Surgery.
    Ghensi P; Cucchi A; Creminelli L; Tomasi C; Zavan B; Maiorana C · The Journal of craniofacial surgery · 2018
    Randomized trial84 participantsAnti-Inflammatory Support forBromelain
  9. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  10. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  11. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsAnti-Inflammatory Support Joint Health forBoswellia
  12. Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials.
    Mendes ML; do Nascimento-Júnior EM; Reinheimer DM; Martins-Filho PR · Medicina oral, patologia oral y cirugia bucal · 2019
    Meta-analysis6 studies pooledAnti-Inflammatory Support forBromelain
  13. Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.
    Müller S; März R; Schmolz M; Drewelow B; Eschmann K; Meiser P · Phytotherapy research : PTR · 2013
    Randomized trial12 participantsAnti-Inflammatory Support forBromelain
  14. An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study.
    Colletti A; Procchio C; Pisano M; Martelli A; Pellizzato M; Cravotto G · Nutrients · 2024
    Randomized trial42 participantsAnti-Inflammatory Support forBromelain
  15. Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.
    Muhammad ZA; Ahmad T · JPMA. The Journal of the Pakistan Medical Association · 2019
    Narrative reviewAnti-Inflammatory Support forBromelain
  16. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  17. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  18. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia
  19. Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.
    Henrotin Y; Pap T; Lieten S; Badot V; Dubuc JE; Urbin-Choffray D; von Eynatten M; Johansen OE; Rau S; Brabants K · RMD open · 2025
    Randomized trial45 participantsJoint Health forBromelain
  20. Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials
    Ueberall MA, Mueller-Schwefe GH, Wigand R, Essner U · Journal of Pain Research · 2016
    Meta-analysis697 participants6 studies pooledJoint Health forBromelain
  21. The safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trial
    Bolten WW, Glade MJ, Raum S, Ritz BW · Arthritis · 2015
    Randomized trial150 participantsJoint Health forBromelain